Lumbrokinase for Adults With Long Covid, Post-treatment Lyme Disease Syndrome, and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Lumbrokinase for Adults With Long Covid, Post-treatment Lyme Disease Syndrome, and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome	Bacterial Infections and Mycoses, Borrelia infectious disease, COVID-19, Chronic Disease, Coronaviridae Infections, Disease Attributes, Infections, Lyme disease, Neuroinflammatory Diseases, Nidovirales infectious disease, Orthocoronavirinae infectious disease, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Post-Infectious Disorders, RNA Virus Infections, bacterial infectious disease, encephalomyelitis, gram-negative bacterial infections, long COVID-19, lung disorder, muscle tissue disorder, musculoskeletal system disorder, myalgic encephalomeyelitis/chronic fatigue syndrome, nervous system disorder, neuromuscular disease, pneumonia, post-treatment Lyme disease syndrome, respiratory system disorder, respiratory tract infectious disorder, spirochaetales infections, tick-borne infectious disease, vector-borne disease, viral infectious disease, viral pneumonia	Recruiting	Phase 1 / Phase 2	2026-03-13		NCT06511050

3 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Columbia University	375
Icahn School of Medicine at Mount Sinai	256
PolyBio Research Foundation	5

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
The Cohen Center for Recovery from Complex Chronic Illnesses (CoRE)	New York	United States	5